Cytokinetics, Incorporated with ticker code (CYTK) have now 15 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between 80 and 41 suggesting an average Analsyt target price of $60.93. Now with the previous closing price of $38.98 this would indicate that there is a potential upside of 56.3%. The day 50 moving average is $36.89 and the 200 day MA is $43.07. The company has a market cap of 3.90B. The current stock price for Coherent Corp. is currently 40.75 USD
The potential market cap would be $6,091,991,007 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 1.06 and a -26.55% return on assets.
